0001127602-14-012478.txt : 20140321
0001127602-14-012478.hdr.sgml : 20140321
20140321161751
ACCESSION NUMBER: 0001127602-14-012478
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140320
FILED AS OF DATE: 20140321
DATE AS OF CHANGE: 20140321
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOGEN IDEC INC.
CENTRAL INDEX KEY: 0000875045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330112644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 7814642000
MAIL ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC
DATE OF NAME CHANGE: 20031112
FORMER COMPANY:
FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE
DATE OF NAME CHANGE: 19970530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DORSA CAROLINE
CENTRAL INDEX KEY: 0001181174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19311
FILM NUMBER: 14710444
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-03-20
0000875045
BIOGEN IDEC INC.
BIIB
0001181174
DORSA CAROLINE
BIOGEN IDEC INC.
225 BINNEY STREET
CAMBRIDGE
MA
02142
1
Common Stock
2014-03-20
4
M
0
10000
53.64
A
24468
D
Common Stock
2014-03-20
4
S
0
2200
347.283
D
22268
D
Common Stock
2014-03-20
4
S
0
2701
348.662
D
19567
D
Common Stock
2014-03-20
4
S
0
4199
349.541
D
15368
D
Common Stock
2014-03-20
4
S
0
900
350.368
D
14468
D
Stock Option (Right to Buy)
53.64
2014-03-20
4
M
0
10000
0
D
2020-01-03
Common Stock
10000
25000
D
Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934
This represents the weighted average price for shares purchased at a range between $347.06 (low) and $347.95 (high).
Full information regarding the number of shares purchased at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
This represents the weighted average price for shares purchased at a range between $348.09 (low) and $349.06 (high).
This represents the weighted average price for shares purchased at a range between $349.11 (low) and $350.08 (high).
This represents the weighted average price for shares purchased at a range between $350.11 (low) and $350.85 (high).
The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 01/04/2010.
Matthew S. Gilman, Attorney in Fact for Caroline D. Dorsa
2014-03-21